Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by Daredevil1964on Sep 28, 2020 9:53am
184 Views
Post# 31628307

RE:Good News Aleafia Settlement

RE:Good News Aleafia SettlementThis will effect the share price. The markets watch the balance sheet, and cash position. This will be highlighted by the media as well since it is a Q1 2021 transaction. What is mis leading is the fact that the Aphia financials makes no statement about compensation to Aleafia for Q1. Instead it posts about the settlement reached by Q4 2020. I was right that this was not dealt with in Q4 of 2020.
<< Previous
Bullboard Posts
Next >>